Improving stability and release kinetics of microensapsulated tetanus toxoid by co-encapsulation of additives

Pharmaceutical Research

Volumn 15, Issue 7, 1998, Pages 1103-1110

  Johansen, Pål ^a   Men, Ying ^b   Audran, Régine ^b   Corradin, Giampietro ^b   Merkle, Hans P ^a   Gander, Bruno ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Antigen delivery; Antigenic stability; PLGA microspheres; Stabilizing additives; Tetanus toxoid

Indexed keywords

POLYGLACTIN; POLYLACTIC ACID; RESOMER; TETANUS TOXOID; UNCLASSIFIED DRUG;

ARTICLE; DRUG MANUFACTURE; DRUG RELEASE; DRUG STABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUOROMETRY; MICROENCAPSULATION; PRIORITY JOURNAL;

CAPSULES; CHEMISTRY, PHARMACEUTICAL; DRUG STABILITY; KINETICS; LACTIC ACID; MICROSPHERES; PHARMACEUTIC AIDS; POLYGLYCOLIC ACID; POLYMERS; TETANUS TOXOID;

EID: 0031850896     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011998615267     Document Type: Article

References (32)

1. B. R. Bloom. Vaccines for the third world. Nature 342:115-120 (1989).
2. A. Gibbons. A booster shot for children's vaccines. Science 225:1351 (1992).
3. P. H. Lambert. Research priorities for vaccines to be used at a global level. Behring Inst. Mitt. 95:1-6 (1994).
4. M. Singh, A. Singh, and G. P. Talwar. Controlled delivery of diphtheria toxoid using biodegradable poly(d.l-lactide) microcapsules. Pharm. Res. 8:958-961 (1991).
5. M. J. Alonso, S. Cohen, T. G. Park, R. K. Gupta, G. R. Siber, and R. Langer. Determinants of release rate of tetanus vaccine from polyester microspheres. Pharm. Rex. 10:945-953 (1993).
6. N. Santiago, S. Haas, and R. A. Banghman. Vehicles for oral immunization. Pharm. Biotech. 6:413-438 (1995).
7. J. H. Eldridge, J. A. Meulbroek, J. K. Staas, T. R. Tice, and R. M. Gilley. Vaccine-containing biodegradable microspheres specifically enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response. Adv. Exp. Med. Biol. 251:191-202 (1989).
8. A. J. Almeida, H. O. Alpar, and M. R. W. Brown. Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly(L-lactic acid) microspheres in rats, rabbits and guinea-pigs. J. Pharm. Pharmacol. 45:198-203 (1993).
9. Y. Men, C. Thomasin, H. P. Merkle, B. Gander, and G. Corradin. A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminium hydroxide. Vaccine 13:683-689 (1995).
10. M. J. Alonso, R. K. Gupta, C. Min, G. R. Siber, and R. Langer. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Vaccine 12:299-306 (1994).
11. G. F. A. Kersten, D. Donders, A. Akkermans, and C. Beuvery. Single shot with tetanus toxoid in biodegradable microspheres protects mice despite acid-induced denaturation of the antigen. Vaccine 14:1627-1632 (1996).
12. C. Thomasin, G. Corradin, Y. Men, H. P. Merkle, and B. Gander, Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co-glycolide) microspheres: importance of polymer degradation. J. Contr. Rel. 41:131-145 (1996).
13. Y. Men, B. Gander, H. P. Merkle, and G. Corradin. Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres. Vaccine 14:1442-1450 (1996).
14. W. Lu and T. G. Park. Protein release from poly(lactic-co-glycolic acid) microspheres: Protein stability problems. J. Pharm. Sci. Tech. 49:13-19 (1995).
15. I. Esparza and T. Kissel. Parameters affecting the immunogenity of microencapsulated tetanus toxoid. Vaccine 10:714-720 (1992).
16. T. Kissel, Y. X. Li, C. Volland, S. Görich, and R. Koneberg. Parenteral protein delivery systems using biodegradable polyesters of ABA block structure, containing hydrophobic poly(lacide-co-glycolide) A blocks and hydrophilic poly(ethylene oxide) B blocks. J. Contr. Rel. 39:315-326 (1995).
17. T. G. Park, W. Lu, and G. Crotts. Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly(D.L lactic acid-co-glycolic acid) microspheres. J. Contr. KeI. 33:211-222 (1995).
18. S. P. Schwendeman, H. R. Costantino, and R. K. Gupta. Stabiliza-tion of tetanus and diphtheria toxoids against moisture-induced aggregation. Proc. Nail. Acad. Sci. USA. 92:11234-11238 (1995).
19. A. -C. Chang and R. K. Gupta. Stabilization of tetanus toxoid in poly(dl-lactic-co-glycolic acid) microspheres for the controlled release of antigen. J Pharm. sci. 85:129-132 (1996).
20. M. Morlock, H. Koll, G. Winter, and T. Kissel. Microencapsulation of rh-erytropoietin, using bidegradable poly(D. L- lactideco-glycolide): protein stability and the effects of stabilizing excipients. Eur. J. Pharm. Biopharm. 43:29-36 (1997).
21. M. Manning, K. Patel, and R. Borchardt. Stability of protein pharmaceuticals. Pharm. Res. 6:903-918 (1989)
22. T. Arakawa, Y. Kita, and J. F. Carpenter. Protein solvent interactions in pharmaceutical formulations. Pharm. Res. 8:285-291 (1991).
23. P. L. Wang and T. P. Johnston. Enhanced stability of two model proteins in an agitated solution environment using poloxamer 407. J. Parent. Sci. Techn. 47:183-189 (1993).
24. R. Wu, M.-M. Georgescu, F. Delpeyroux, S. Guillot, J. Balanant, K. Simpson, and R. Crainic. Thermostabilization of live virus vaccines by heavy water. Vaccine 13:1058-1063 (1995).
25. B. Gander, P. Johansen, H. Nam-Trân, and H. P. Merkle. Thermodynamic approach to protein microencapsulation into poly(d,l-lactide) by spray drying. Int. J. Pharm. 129:51-61 (1996).
26. C. Thomasin, P. Johansen, R. Alder, R. Bemsel, G. Hottinger., H. Altorfer, A. D. Wright, E. Wehrli, H. P. Merkle, and B. Gander. A contribution to overcoming the problem of residual solvents in biodegradable microspheres prepared by coacervation. Eur. J. Pharm. Biopharm. 42:16-24 (1996).
27. R. K. Gupta, A. C. Chang, P. Griffin, R. Rivera, Y. Y. Guo, and G. R. Siber. Determination of protein loading in biodegradable polymer microspheres containing tetanus toxoid. Vaccine 15:672-678 (1997).
28. D. K. L. Xing, K. McLellan, M. J. Corbel, and D. Sesardic. Estimation of antigenic tetanus toxoid extracted from biodegradable microspheres. Biologicals 24:57-65 (1996).
29. D. K. L. Xing, D. T. Crane, B. Bolgiano, M. J. Corbel, C. Jones, and D. Sesardic. Physicochemical and immunologocal studies on the stability of free and microsphere-encapsulated tetanus toxoid in vitro. Vaccine 14:1205-1213 (1996).
30. P. Johansen, H. P. Merkle, and B. Gander. Physico-chemical and antigenic properties and improved stability of tetanus and diphtheria toxoids. Vaccine. Submitted.
31. P. Johansen, G. Corradin, H. P. Merkle, and B. Gander. Release of tetanus toxoid from adjuvants and PLGA microspheres: how experimental set-up und surface adsorption fool the pattern. J. Contr. Rel. Submitted.
32. Y. Zhou and C. K. Hall. Solute excluded-volume effects on the stability of globular proteins: a statistical thermodynamic theory. Biopolymers 3:273-284 (1996).